Mettler-Toledo International, Inc. $MTD Shares Purchased by Boston Trust Walden Corp

Boston Trust Walden Corp increased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 1.2% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 41,696 shares of the medical instruments supplier’s stock after acquiring an additional 482 shares during the period. Boston Trust Walden Corp owned approximately 0.21% of Mettler-Toledo International worth $52,587,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Nordea Investment Management AB lifted its position in Mettler-Toledo International by 11.9% in the fourth quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock valued at $220,718,000 after buying an additional 16,777 shares during the last quarter. Pensionfund Sabic acquired a new stake in shares of Mettler-Toledo International during the fourth quarter valued at about $1,255,000. M&T Bank Corp raised its stake in shares of Mettler-Toledo International by 2,813.6% in the 4th quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock valued at $173,165,000 after acquiring an additional 119,942 shares during the period. Crossmark Global Holdings Inc. raised its stake in shares of Mettler-Toledo International by 34.3% in the 4th quarter. Crossmark Global Holdings Inc. now owns 4,150 shares of the medical instruments supplier’s stock valued at $5,786,000 after acquiring an additional 1,060 shares during the period. Finally, Legal & General Group Plc lifted its holdings in shares of Mettler-Toledo International by 3.5% in the 3rd quarter. Legal & General Group Plc now owns 169,256 shares of the medical instruments supplier’s stock worth $207,780,000 after acquiring an additional 5,672 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Trading Up 0.6%

Mettler-Toledo International stock opened at $1,307.91 on Friday. The company has a fifty day simple moving average of $1,175.62 and a 200-day simple moving average of $1,289.99. The stock has a market cap of $26.43 billion, a P/E ratio of 30.67, a price-to-earnings-growth ratio of 2.71 and a beta of 1.24. Mettler-Toledo International, Inc. has a 12-month low of $1,023.05 and a 12-month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating the consensus estimate of $8.70 by $0.21. The firm had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.Mettler-Toledo International’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, sell-side analysts forecast that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently commented on MTD. Morgan Stanley lowered their price target on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 12th. Wolfe Research started coverage on Mettler-Toledo International in a report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Robert W. Baird decreased their target price on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Stifel Nicolaus lowered their target price on Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a report on Monday, May 18th. Finally, JPMorgan Chase & Co. dropped their target price on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $1,408.55.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.